Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Surgical techniques for treating pain after cancer-related amputations

Official title: Targeted Muscle Reinnervation (TMR) Versus Regenerative Peripheral Nerve Interfaces (RPNI) Versus the Combined Technique of TMR-RPNI to Reduce Chronic and Phantom Limb Pain in Oncologic Amputees: A Randomized Control Pilot Study

Run by M.D. Anderson Cancer Center · NCT06840262 · Data updated 2026-11-12

This study is testing two different surgical methods to see if they can help cancer patients who have had amputations feel less pain in their residual limbs and reduce phantom limb pain.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment57 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedAugust 10, 2020
Main results expectedFebruary 2, 2027
Study endsFebruary 2, 2027
Registry record updatedOctober 20, 2026
Trial IDNCT06840262 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are undergoing an amputation for oncologic reasons and have suitable nerve structures for the surgical techniques.

Probably not a fit

Patients who are under 18, unable to provide consent, or receiving amputations for non-oncologic reasons may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of two surgical techniques, targeted muscle re-innervation (TMR) and regenerative peripheral nerve interfaces (RPNI), both alone and in combination, to alleviate chronic residual limb and phantom limb pain in cancer patients who have undergone amputation. The study aims to determine the relative effectiveness of these techniques using validated pain assessment scales and to estimate pain medication use and prosthetic use among participants. Patients will be randomized into three groups to receive one of the surgical interventions, followed by follow-up assessments at 3, 6, and 12 months post-procedure.

Why it matters

Potential benefit: If successful, this study could significantly reduce chronic pain and improve quality of life for cancer patients who have undergone amputations.

How similar studies have gone: While the techniques of TMR and RPNI are established, the combination approach being evaluated in this trial is relatively novel and has not been extensively tested in this specific patient population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients greater than or equal to 18 years of age who are receiving an amputation for oncologic reasons
* Patients with available mixed major nerves and donor motor nerves in the amputation stump or reconstructive tissue
* Patients able to complete informed consent

Exclusion Criteria:

* Patients under 18 years of age
* Patients unable to give consent
* Patients receiving an amputation for non-oncologic purposes
* Patients with amputations performed for immediate palliation (life expectancy less than 3 months), as this technique takes a minimum of 3-6 months for effect
* Patients with multiple limb amputations
* Patients receiving nerve management in a delayed fashion (patients who have previously received an amputation and present with neuroma)

Where it's running

  • M D Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Margaret S Roubaud — M.D. Anderson Cancer Center

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.